Sangamo Therapeutics (SGMOQ) Treasury Shares (2011 - 2025)

Sangamo Therapeutics' Treasury Shares history runs 15 years deep, the most recent figure standing at $5.6 million for Q4 2025.

• On a quarterly basis, Treasury Shares fell 48.79% year-over-year to $5.6 million in Q4 2025; TTM through Dec 2025 was $5.6 million, a 48.79% decrease from a year earlier, with the FY2025 full-year figure at $5.6 million, down 48.79% from the prior year.
• Treasury Shares slipped to $5.6 million in Q4 2025 per SGMOQ's latest filing, from $11.0 million in the prior quarter.
• Across five years, Treasury Shares topped out at $11.0 million in Q4 2024 and bottomed at $3.1 million in Q4 2021.
• The 5-year median for Treasury Shares is $5.6 million (2025), against an average of $6.2 million.
• Across the five-year window, Treasury Shares surged 82.11% in 2024 and sank 48.79% in 2025, its largest moves.
• Year by year, Treasury Shares stood at $3.1 million in 2021, then surged by 67.02% to $5.2 million in 2022, then gained by 15.43% to $6.1 million in 2023, then jumped by 82.11% to $11.0 million in 2024, then sank by 48.79% to $5.6 million in 2025.
• Per Business Quant, the three latest SGMOQ Treasury Shares figures stand at $5.6 million (Q4 2025), $11.0 million (Q4 2024), and $6.1 million (Q4 2023).